Table 2.
Characteristics related to DBPCFC of the FAS population (N = 30)
| Characteristics | |
|---|---|
| Immediate reactions to CMP, N (%) | 22 (73.3) |
| Types of immediate reactions to CMP, N (%) | |
| Digestive signs | 19 (86.4) |
| Local cutaneous signs | 7 (31.8) |
| General cutaneous signs | 6 (27.3) |
| Laryngeal edema | 2 (9.1) |
| Bronchospasm | 1 (4.5) |
| Delayed reactions to CMP, N (%) | 10 (33.3) |
| Types of delayed reactions to CMP, N (%) | |
| Digestive | 8 (80.0) |
| Cutaneous | 5 (50.0) |
| Cumulative dose of non-hydrolyzed CMP-based formula eliciting immediate reactions, median [minimum-maximum], ml | 15 [5–95] |
| Time for eliciting immediate reactions, mean (± SD), minutes | 83.8 (16.1) |
N number of subjects